scholarly article | Q13442814 |
P50 | author | Angelique Whitehurst | Q96222252 |
P2093 | author name string | Zane A Gibbs | |
P2860 | cites work | Meiosis-like Functions in Oncogenesis: A New View of Cancer. | Q50072762 |
ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors | Q50335771 | ||
The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma | Q50420957 | ||
No circadian rhythms in testis: Period1 expression is clock independent and developmentally regulated in the mouse. | Q52110503 | ||
Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila. | Q52713517 | ||
OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer. | Q53589009 | ||
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives. | Q54945263 | ||
The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma | Q88964948 | ||
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma | Q89068505 | ||
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma | Q90722961 | ||
HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress | Q91303227 | ||
LAP2alpha-binding protein LINT-25 is a novel chromatin-associated protein involved in cell cycle exit | Q24295870 | ||
MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents | Q24297439 | ||
Synaptonemal complex protein SYCP3 impairs mitotic recombination by interfering with BRCA2 | Q24298264 | ||
MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases | Q24300816 | ||
MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription | Q24301553 | ||
Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer | Q24301740 | ||
Tex14, a Plk1-regulated protein, is required for kinetochore-microtubule attachment and regulation of the spindle assembly checkpoint | Q24306949 | ||
Human NUF2 interacts with centromere-associated protein E and is essential for a stable spindle microtubule-kinetochore attachment | Q24307444 | ||
Human TFDP3, a novel DP protein, inhibits DNA binding and transactivation by E2F | Q24309023 | ||
Novel centrosome protein, TCC52, is a cancer-testis antigen | Q24309533 | ||
Mps1 phosphorylates Borealin to control Aurora B activity and chromosome alignment | Q24310028 | ||
Luzp4 defines a new mRNA export pathway in cancer cells | Q24318387 | ||
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma | Q24319940 | ||
The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling | Q24336423 | ||
Cancer/Testis Antigen PASD1 Silences the Circadian Clock | Q24337215 | ||
Human neoplasms elicit multiple specific immune responses in the autologous host | Q24564371 | ||
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening | Q24564781 | ||
KNL1 and the CENP-H/I/K complex coordinately direct kinetochore assembly in vertebrates | Q24654035 | ||
Cep55, a microtubule-bundling protein, associates with centralspindlin to control the midbody integrity and cell abscission during cytokinesis | Q24670163 | ||
hNuf2 inhibition blocks stable kinetochore-microtubule attachment and induces mitotic cell death in HeLa cells | Q24674081 | ||
Nuclear receptors and their selective pharmacologic modulators | Q26825692 | ||
Structure, chromosomal localization, and expression of 12 genes of the MAGE family | Q28238754 | ||
The testis in immune privilege | Q28263610 | ||
TGFbeta in Cancer | Q28288866 | ||
T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation | Q28304881 | ||
Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer | Q28975773 | ||
Cancer/testis antigens, gametogenesis and cancer | Q29616129 | ||
Multiple cancer testis antigens function to support tumor cell mitotic fidelity. | Q29871492 | ||
High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells | Q30499296 | ||
KNL1/Spc105 recruits PP1 to silence the spindle assembly checkpoint | Q30500882 | ||
Identification of DPPA4 and DPPA2 as a novel family of pluripotency-related oncogenes. | Q30662635 | ||
Identification of cancer/testis genes by database mining and mRNA expression analysis | Q31045922 | ||
Synthetic lethal screen identification of chemosensitizer loci in cancer cells | Q33281866 | ||
Rapid evolution of cancer/testis genes on the X chromosome | Q33285549 | ||
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens | Q33374216 | ||
Genome-wide analysis of cancer/testis gene expression | Q33393581 | ||
Degradation of cell proteins and the generation of MHC class I-presented peptides | Q33652524 | ||
Identification of cancer/testis-antigen genes by massively parallel signature sequencing | Q33841222 | ||
Rapid evolution of male reproductive genes in the descent of man. | Q33888839 | ||
Tumor Antigen Acrosin Binding Protein Normalizes Mitotic Spindle Function to Promote Cancer Cell Proliferation | Q34168649 | ||
Meta-analysis of expression of l(3)mbt tumor-associated germline genes supports the model that a soma-to-germline transition is a hallmark of human cancers | Q34200595 | ||
Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer | Q34283691 | ||
The journey from autologous typing to SEREX, NY-ESO-1, and cancer/testis antigens | Q34381251 | ||
The kinetochore encodes a mechanical switch to disrupt spindle assembly checkpoint signalling | Q34479683 | ||
SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity. | Q34558043 | ||
FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway | Q34604380 | ||
Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen | Q34721861 | ||
Melanoma, nevogenesis, and stem cell biology | Q34826179 | ||
Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2. | Q35110943 | ||
A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets | Q35429274 | ||
Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers | Q35812762 | ||
Dynamic localization of Mps1 kinase to kinetochores is essential for accurate spindle microtubule attachment | Q35989892 | ||
JNK-associated Leucine Zipper Protein Functions as a Docking Platform for Polo-like Kinase 1 and Regulation of the Associating Transcription Factor Forkhead Box Protein K1. | Q36444130 | ||
KAP1 Recruitment of the 7SK snRNP Complex to Promoters Enables Transcription Elongation by RNA Polymerase II. | Q36467037 | ||
Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types | Q36534662 | ||
Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers | Q36757298 | ||
The SPANX gene family of cancer/testis-specific antigens: rapid evolution and amplification in African great apes and hominids | Q36853782 | ||
Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance | Q37012226 | ||
The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion | Q37046694 | ||
A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis | Q37072996 | ||
Metabolism and cancer: the circadian clock connection | Q37638137 | ||
KAP1 protein: an enigmatic master regulator of the genome | Q37886421 | ||
Circadian molecular clocks and cancer | Q38150021 | ||
Cause and consequence of cancer/testis antigen activation in cancer | Q38155597 | ||
An in vivo genetic screen in Drosophila identifies the orthologue of human cancer/testis gene SPO11 among a network of targets to inhibit lethal(3)malignant brain tumour growth | Q38429180 | ||
The MAGE protein family and cancer. | Q38581531 | ||
Targeting Mitosis in Cancer: Emerging Strategies | Q38641647 | ||
Cyclin A1 and P450 Aromatase Promote Metastatic Homing and Growth of Stem-like Prostate Cancer Cells in the Bone Marrow. | Q38790631 | ||
Plk1 and Mps1 Cooperatively Regulate the Spindle Assembly Checkpoint in Human Cells | Q38859208 | ||
The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. | Q39024088 | ||
A majority of the cancer/testis antigens are intrinsically disordered proteins | Q39063386 | ||
ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication | Q39406153 | ||
Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin | Q39634857 | ||
HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL. | Q39943400 | ||
Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma | Q39985993 | ||
MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines | Q40066322 | ||
Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis | Q40213144 | ||
Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture | Q40296439 | ||
Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes | Q40377860 | ||
A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer. | Q40399446 | ||
Cancer/testis antigen PIWIL2 suppresses circadian rhythms by regulating the stability and activity of BMAL1 and CLOCK | Q41550169 | ||
Role of A-Kinase anchor protein (AKAP4) in growth and survival of ovarian cancer cells | Q41593068 | ||
IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC. | Q42083354 | ||
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry | Q42143897 | ||
Degradation of AMPK by a cancer-specific ubiquitin ligase | Q42276010 | ||
TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer | Q42512528 | ||
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E | Q42603854 | ||
Circadian disruption in experimental cancer processes | Q43204662 | ||
Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint. | Q43680754 | ||
Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma. | Q45927301 | ||
Cell-cell adhesion genes CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal carcinomas. | Q46521313 | ||
Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect | Q46618175 | ||
The centrosomal localization of KM-HN-1 (MGC33607) depends on the leucine zipper motif and the C-terminal coiled-coil domain | Q46832038 | ||
Genome-wide identification of cancer/testis genes and their association with prognosis in a pan-cancer analysis | Q47129963 | ||
Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA. | Q47289701 | ||
Piwi proteins and piRNAs in mammalian oocytes and early embryos | Q47426102 | ||
Testes-specific protease 50 promotes cell proliferation via inhibiting activin signaling | Q47986499 | ||
MAEL contributes to gastric cancer progression by promoting ILKAP degradation. | Q49678835 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 701-712 | |
P577 | publication date | 2018-09-20 | |
P1433 | published in | Trends in cancer | Q27726777 |
P1476 | title | Emerging Contributions of Cancer/Testis Antigens to Neoplastic Behaviors | |
P478 | volume | 4 |
Q102388731 | Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma |
Q91622119 | EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival |
Q99402564 | Emerging Roles of the MAGE Protein Family in Stress Response Pathways |
Q91588863 | Epigenetic activation of POTE genes in ovarian cancer |
Q64230153 | Genetic screens reveal mechanisms for the transcriptional regulation of tissue-specific genes in normal cells and tumors |
Q92785287 | HSF2BP negatively regulates homologous recombination in DNA interstrand crosslink repair |
Q92128948 | Meiotic gene activation in somatic and germ cell tumours |
Q100378834 | Sperm-specific COX6B2 enhances oxidative phosphorylation, proliferation, and survival in human lung adenocarcinoma |
Q96222254 | The testis protein ZNF165 is a SMAD3 cofactor that coordinates oncogenic TGFβ signaling in triple-negative breast cancer |